drugset / Trial / NCT01902459
EVARREST™ Fibrin Sealant Patch Post-Market Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the clinical utility of EVARREST™ Fibrin Sealant Patch (Fibrin Pad) as an adjunct to hemostasis in soft tissue bleeding during intra-abdominal (stomach area), retroperitoneal (hip and stomach area), pelvic (hip area) and non-cardiac thoracic (chest area) surgery.
Timeline
- Start
- 2013-07-01
- Primary completion
- 2015-08-01
- Completion
- 2015-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fibrin Pad | Protein / enzyme biologic | — | — |